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Editorial Life v2.0 - Quo vadis Homo sapiens?
Stephan M Feller
Abstract
This editorial briefly discusses the implications of the recent report by Craig Venter et al. on re-creating Mycoplasma 
mycoides as a synthetic life form.
Some of our fellow human beings will surely see the 20th
of May 2010 as the day of our second eviction from para-
dise, or even the first step on a sliding slope to hell. For
others it may mark the day when hope for a new age of
human prosperity emerged, similar to the day when Pro-
metheus brought fire to the humans. Prometheus, of
course, personally paid dearly for his action and we can
only hope that history does not repeat itself in this aspect;
there is no doubt in my mind that the 'infotainment'
media will once again play a prominent role in hyping up
this latest accomplishment, thereby generating unneces-
sary anxiety or even hate and a thoroughly unrealistic
picture of the possible spin-offs.
So what has actually happened?
Craig Venter, a seemingly tireless maverick/maniac/
visionary, and his team have succeeded in copying, i.e. re-
producing, and slightly modifying an existing life form -
something that all living cells have been able to do for a
long time already. The difference is, of course, that Homo
sapiens can now re-create, and - at least on the DNA level
- at will modify, Mycoplasma mycoides. This is really
quite an amazing accomplishment and it was over a
decade in the making [1,2]. Amongst other things, this
're-booting' of a cell shows that - at least in this simple
organism - the 'programmed software', i.e. the genetic
blueprint, seems to be able to fully instruct and facilitate
the complete replacement of the cellular 'hardware'.
Although this miniscule creature is potentially the most
lowly version of all cellular life forms, its re-creation is
clearly the beginning of many things. Not only is it the
start of a new dimension in synthetic biology, it is proba-
bly also the real birthday of systems biology. So far, most
so-called systems biologist have done at best 'sub-systems
biology', but the new technologies developed by Venter et
al. will enable completely unprecedented ways of system-
atic systemic experimentation with living cells. They
should also make possible quite novel types of experi-
ments for evolution biologists, signal transduction
researchers and many others.
This is all good and well for the 'afficionados', but for
the general public the real 'juice' is in the exciting new
possibilities for practical applications, which are seem-
ingly endless - if these technologies can also be applied to
more complex genomes. A wide range of potentially use-
ful, or harmful, but certainly patentable and commer-
cially extremely interesting creatures may emerge.
Should we ever allow such human creations to live and
work in the wild? Let them eat up oil spills or toxins? If
not, this will limit their applications severely; and if we
prohibit them to roam freely, what will happen if such
creatures escape unintentionally or through a deranged
individual? This is quite likely to happen, especially when
commercialisation becomes a significant issue, which it
probably will. Must all newly created life forms hence
carry a fail-safe self-destruction device within them? If so,
is it even possible to create a truly fail-safe system?
Should the creation of new life forms be limited to
microbes and other simple unicellular organisms? How
do we prevent them from becoming pathogenic by hori-
z o n t a l  g e n e  t r a n s f e r  e t c . ?  D o  w e  w a n t  t h e m  o n  t h i s
planet, or should they be exiled, say onto the moon?
Of course, the synthetic organism currently at hand
seems to be rather benign and, being a mutant version
with over a dozen genes deleted, may at best give goats a
mild mastitis, even if wilfully introduced into them. How-
ever, this is unlikely to be always true for future synthetic
species, so the list of emerging questions is long, indicat-
ing that strict regulation and monitoring of such life v2.0
research activities will be required until we learn much
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more. Extensive debates about potential risks and appli-
cations by molecular biologists, ethics experts, legislators
and the general public are clearly warranted which go
beyond the commendable initial steps already made in
this context [3,4]. Globally effective laws need to be
developed and implemented within the next decade.
In a nutshell, life on this planet has once again become
just a little more complex.
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